[Federal Register Volume 84, Number 213 (Monday, November 4, 2019)]
[Notices]
[Pages 59377-59378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23999]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-20-19BJD]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Monitoring and Reporting for the Overdose 
Data to Action Cooperative Agreement'' to the Office of Management and 
Budget (OMB) for review and approval. CDC previously published a 
``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on July 25, 2019 to obtain comments from the 
public and affected agencies. CDC did not receive comments related to 
the previous notice. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Monitoring and Reporting for the Overdose Data to Action 
Cooperative Agreement--New--National Center for Injury Prevention and 
Control (NCIPC), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    This new data collection effort is to collect information from 
grantees

[[Page 59378]]

funded under the Overdose Data to Action (OD2A) cooperative agreement 
program. OMB approval is requested for three years.
    Drug overdose deaths in the United States increased by 18% per year 
from 2014 to 2016. Opioid overdose deaths have increased five-fold from 
1999 to 2016, and in 2017, there were more than 47,000 deaths 
attributed to opioids. In 2017, the opioid epidemic was declared a 
public health emergency by the U.S. Department of Health and Human 
Services (HHS).
    The purpose of the Overdose Data to Action cooperative agreement 
program, administered by the Centers for Disease Control and Prevention 
(CDC), is to support state and local public health jurisdictions in 
obtaining high quality, complete, and timely data on opioid prescribing 
and overdoses, and to use this data to inform prevention and response 
efforts. There are two required components of this award: A 
surveillance component and a prevention component. The intent is to 
ensure that funded grantees are well equipped to do rigorous work under 
both components.
    CDC requests OMB approval to collect information from 66 funded 
jurisdictions about the resources, plans, and activities needed to 
control the epidemic of fatal and nonfatal overdoses caused by opioids 
and other drugs. Awardees will submit to CDC an evaluation and 
performance measurement plan using a preformatted template; an 
organizational capacity assessment using an online tool; and an 
electronic activity progress report and work plan tool. Burden per 
response will be highest for the first year of funding during initial 
population of each electronic reporting form. In subsequent years, 
burden per response will decrease as awardees will only need to update 
the information requested on each form. CDC will also collect a one-
time Surveillance Data Dissemination Plan which is not part of the 
annual reporting requirement.
    The information collected will provide crucial data to CDC for 
program monitoring and budget tracking, to improve CDC-recipient 
communications, and to inform technical assistance and guidance 
documents produced by CDC to support program implementation among 
funded grantees. It will also provide CDC with the capacity to respond 
in a timely manner to requests for information about the program from 
HHS, the White House, Congress, and other sources. The data will be 
analyzed using descriptive, summary statistics, and qualitative 
summaries.
    Participation in this information collection is required for funded 
awardees. There are no costs to the respondents other than their time. 
The total estimated annualized burden hours are 1,342.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
        Type of respondents                   Form name              Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Overdose Data to Action funded       Evaluation and Performance               22               1              12
 jurisdictions (State, territories,   Measuring Plan Template--
 counties and cities) and their       Initial Population.
 Designated Delegates.
                                     Evaluation and Performance               66               1               4
                                      Measuring Plan Template--
                                      Annual reporting.
                                     Organizational Capacity                  22               1               1
                                      Assessment--Initial
                                      Population.
                                     Organizational Capacity                  66               1               1
                                      Assessment--Annual
                                      Reporting.
                                     Activity Progress Report                 22               1              20
                                      and Work Plan Tool--
                                      Initial Population.
                                     Activity Progress Report                 66               1               4
                                      and Work Plan Tool--Annual
                                      Reporting.
                                     Surveillance Data                        22               1               1
                                      Dissemination Plan Tool.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-23999 Filed 11-1-19; 8:45 am]
BILLING CODE 4163-18-P